Axcella Health Inc.
AXLA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.23 | 6.10 | 1.44 | -0.42 |
| FCF Yield | -13.35% | -2.74% | -1.21% | -3.07% |
| EV / EBITDA | -7.60 | -32.22 | -75.65 | -27.87 |
| Quality | ||||
| ROIC | -1,142.66% | -135.00% | -55.01% | -67.85% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.86 | 0.84 | 0.88 | 0.86 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -28.48% | -8.97% | 2.13% | -62.88% |
| Safety | ||||
| Net Debt / EBITDA | 0.22 | -0.02 | 0.86 | 1.17 |
| Interest Coverage | -24.10 | -21.20 | -17.90 | -16.92 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |